The new law opens the Texas Compassionate Use Program to include those suffering from chronic pain and other newly eligible conditions. It also expands the variety of cannabis formulations that patients possess and significantly increases the total number of state-licensed dispensaries that can operate in the state.
“Recreational cannabis laws result in significant relative declines in prescription drug claims. … The legalization of cannabis offers a potential substitute to traditional prescription drugs and alternative methods for health maintenance.”
“These numbers show meaningful changes in disturbed sleep and fatigue for patients after starting medical cannabis.”
“In a healthy democracy, those with competing visions on public policy vie for voters’ support and abide by their voting decisions. However, it is becoming clear that those who oppose marijuana policy reform would rather take voters out of the equation altogether.”
The new law defines “cannabinoid edible products” as “soft or hard lozenges in a geometric square shape into which a cannabinoid concentrate or the dried leaves or flowers of the plant of the genus cannabis is incorporated.”
“The individuals who are continuing to be opposed are absolutely disregarding the fact that 71 percent of people in this state support safe and regulated medical cannabis.”
“The results of this study indicate that cannabis may be a relatively safe and effective treatment for chronic pain, sleep disturbances, and other conditions associated with aging, leading to subsequent reductions in prescription drug use and healthcare costs, as well as significant improvements in quality of life.”
“The current findings suggest [that] cannabis-based medicinal products may be effective in reducing suicidal ideation, as well as other facets of health and well-being.”